Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

723
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
723
Multipotency and Niche of Bulge Stem Cell01:06

Multipotency and Niche of Bulge Stem Cell

4.1K
A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...
4.1K
Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

417
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
417

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral and cutaneous manifestations of viral and bacterial infections: Not only COVID-19 disease.

Clinics in dermatology·2021
Same author

Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question.

Skin appendage disorders·2021
Same author

Study on the impact of sexually transmitted infections on Quality of Life, mood and sexual function.

Italian journal of dermatology and venereology·2020
Same author

Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.

Journal of medical virology·2020
Same author

Sexually transmitted infections in male prison inmates. Prevalence, level of knowledge and risky behaviours.

Le infezioni in medicina·2020
Same author

Tinidazole: Another Therapeutic Option for Syphilis?

Journal of clinical pharmacology·2020

Related Experiment Video

Updated: Jan 4, 2026

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
03:22

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

15.5K

Telogen effluvium: a comprehensive review.

Alfredo Rebora1

  • 1University of Genoa, Genoa, Italy.

Clinical, Cosmetic and Investigational Dermatology
|November 6, 2019
PubMed
Summary
This summary is machine-generated.

Telogen effluvium (TE) is excessive hair shedding, often impacting women. This essay clarifies TE diagnosis, classification, differentiation from androgenetic alopecia (AGA), and management, emphasizing patient empathy.

Keywords:
alopeciahairtelogen effluvium

More Related Videos

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

9.3K
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:11

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

193

Related Experiment Videos

Last Updated: Jan 4, 2026

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
03:22

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

15.5K
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
06:41

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

9.3K
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:11

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

193

Area of Science:

  • Dermatology
  • Trichology

Background:

  • Excessive hair shedding, known as telogen effluvium (TE), is a frequent concern, particularly among women.
  • TE presents diagnostic and classification challenges, often co-occurring with androgenetic alopecia (AGA).

Purpose of the Study:

  • To address key issues in diagnosing and managing telogen effluvium.
  • To clarify diagnostic criteria, classification, and differentiation from other hair loss conditions.
  • To highlight the importance of patient-centered care in managing TE.

Main Methods:

  • Review of diagnostic criteria for TE.
  • Discussion of classification systems for hair shedding disorders.
  • Analysis of the relationship between TE and androgenetic alopecia (AGA).
  • Evaluation of trichodynia as a symptom.
  • Assessment of histopathology findings in TE.
  • Outline of management strategies from diagnosis to treatment.

Main Results:

  • Defines criteria for diagnosing the severity of hair loss in TE.
  • Highlights the heterogeneity of TE and the need for classification.
  • Differentiates TE from androgenetic alopecia (AGA).
  • Discusses the diagnostic value and frequency of trichodynia.
  • Explains the nonspecific nature of histopathology in TE diagnosis.
  • Provides a comprehensive overview of TE management.

Conclusions:

  • Accurate diagnosis and classification of TE are crucial.
  • Distinguishing TE from AGA is essential for appropriate treatment.
  • Management requires a thorough approach, considering patient impact and empathy.
  • Dermatologists should validate patient concerns regarding hair loss.